BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 6179832)

  • 1. [Separation of red blood cells from G6PD-deficient patients in dextran density gradients].
    Grieger M; Bier K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(2):290-306. PubMed ID: 6179832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New stable mutant (Gd(-) variants: G6PD Tashkent and G6PD Nucus. Molecular basis of hereditary enzyme deficiency.
    Yermakov N; Tokarev Ju; Chernjak N; Schönian G; Grieger M; Guckler A; Jacobasch G; Mahmudova M; Bahramov S
    Acta Biol Med Ger; 1981; 40(4-5):559-62. PubMed ID: 7315103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red cell G6PD decay in circulating cells: a possible marker for variants identification.
    Pescarmona GP; Turrini F; Naitana A; Bosia A; Perroni L
    Biomed Biochim Acta; 1983; 42(11-12):S291-2. PubMed ID: 6675706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of the hexose monophosphate shunt in glucose-6-phosphate dehydrogenase deficiency and closely interrelated reactions.
    Jacobasch G; Bleiber R; Schönian G
    Haematologia (Budap); 1982 Dec; 15(4):401-7. PubMed ID: 7186479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of hemolytic anemia in G6PD- subjects. Multifactorial cluster analysis of biochemical characteristics of red cell age groups.
    Yermakov NV; Jacobasch G; Krekhnov BV; Ermakova TA
    Biomed Biochim Acta; 1990; 49(2-3):S242-6. PubMed ID: 2386512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diurnal fluctuation of leukocyte G6PD activity. A possible explanation for the normal neutrophil bactericidal activity and the low incidence of pyogenic infections in patients with severe G6PD deficiency in Israel.
    Wolach B; Ashkenazi M; Grossmann R; Gavrieli R; Friedman Z; Bashan N; Roos D
    Pediatr Res; 2004 May; 55(5):807-13. PubMed ID: 14973180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behaviour of cell physiological and biochemical indicators of maturation and aging of red blood cells in density fractionated red blood cells during a bleeding anaemia of the rabbit.
    Gross J; Coutelle C; Schulz W; Schmalisch G; Rosenthal S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(4):515-25. PubMed ID: 2431973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phospholipid content and phospholipid fatty acid composition of red blood cells in enzyme defect hemolytic anemias.
    Bleiber R; Eggert W; Reichmann G; Kunze D
    Acta Biol Med Ger; 1981; 40(9):1133-37. PubMed ID: 7340336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a novel mouse model of severe glucose-6-phosphate dehydrogenase (G6PD)-deficiency for in vitro and in vivo assessment of hemolytic toxicity to red blood cells.
    Ko CH; Li K; Li CL; Ng PC; Fung KP; James AE; Wong RP; Gu GJ; Fok TF
    Blood Cells Mol Dis; 2011 Oct; 47(3):176-81. PubMed ID: 21839656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marked decrease in specific activity contributes to disease phenotype in two human glucose 6-phosphate dehydrogenase mutants, G6PD(Union) and G6PD(Andalus).
    Wang XT; Lam VM; Engel PC
    Hum Mutat; 2005 Sep; 26(3):284. PubMed ID: 16088936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural variants of human glucose 6-phosphate dehydrogenase (G6PD): role of intracellular decay in the expression of deficiency.
    De Flora A; Morelli A; Benatti U
    Biomed Biochim Acta; 1983; 42(11-12):S247-52. PubMed ID: 6675698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of NADPH in the development of neonatal jaundice with G6PD deficiency].
    Chen F; Zhang Y; Wu Z
    Zhonghua Yi Xue Za Zhi; 1997 Apr; 77(4):278-81. PubMed ID: 9596929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemolytic crises caused by Hoya carnosa in a patient with G6PD deficiency.
    Kuliszkiewicz-Janus M; Tyran W; Szajerka G
    Acta Haematol Pol; 1992; 23(1):63-7. PubMed ID: 1615754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between the enzyme activity, lipid peroxidation and red blood cells deformability in hemizygous and heterozygous glucose-6-phosphate dehydrogenase deficient individuals.
    Gurbuz N; Yalcin O; Aksu TA; Baskurt OK
    Clin Hemorheol Microcirc; 2004; 31(3):235-42. PubMed ID: 15322329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Impaired glutathione metabolism in hemolytic anemia].
    Kondo T
    Rinsho Byori; 1990 Apr; 38(4):355-9. PubMed ID: 2195189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical utility of fractionating erythrocytes into "Percoll" density gradients.
    Mosca A; Paleari R; Modenese A; Rossini S; Parma R; Rocco C; Russo V; Caramenti G; Paderi ML; Galanello R
    Adv Exp Med Biol; 1991; 307():227-38. PubMed ID: 1666816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential use of xylitol in glucose-6-phosphate dehydrogenase deficiency anemia.
    Wang YM; Patterson JH; Van Eys J
    J Clin Invest; 1971 Jul; 50(7):1421-8. PubMed ID: 4397414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of decreased erythrocyte deformability and survival in glucose 6-phosphate dehydrogenase mutants.
    Flynn TP; Johnson GJ; Allen DW
    Prog Clin Biol Res; 1981; 56():231-49. PubMed ID: 7330011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red cell enzymopathies as a model of inborn errors of metabolism.
    Miwa S; Kanno H; Hirono A; Fujii H
    Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():112-9. PubMed ID: 8629088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of superoxide dismutase (sod) in erythrocytes in glucose-6-phosphate dehydrogenase deficiency (G6PD-deficiency)].
    Grieger M; Schulz S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(3):427-36. PubMed ID: 6194077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.